SMT201600219B - Ormone follicolo-stimolante ricombinante umano migliorato - Google Patents

Ormone follicolo-stimolante ricombinante umano migliorato

Info

Publication number
SMT201600219B
SMT201600219B SM201600219T SM201600219T SMT201600219B SM T201600219 B SMT201600219 B SM T201600219B SM 201600219 T SM201600219 T SM 201600219T SM 201600219 T SM201600219 T SM 201600219T SM T201600219 B SMT201600219 B SM T201600219B
Authority
SM
San Marino
Prior art keywords
human
hormone
stimulating
follicle
improved
Prior art date
Application number
SM201600219T
Other languages
English (en)
Inventor
Steffen Goletz
Lars Stöckl
Original Assignee
Glycotope Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43242604&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600219(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glycotope Gmbh filed Critical Glycotope Gmbh
Publication of SMT201600219B publication Critical patent/SMT201600219B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SM201600219T 2010-08-04 2016-07-06 Ormone follicolo-stimolante ricombinante umano migliorato SMT201600219B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2010/004769 WO2012016576A1 (en) 2010-08-04 2010-08-04 Improved recombinant human follicle-stimulating hormone
EP11757190.1A EP2601210B1 (en) 2010-08-04 2011-08-04 Improved recombinant human follicle-stimulating hormone
PCT/EP2011/063492 WO2012017058A1 (en) 2010-08-04 2011-08-04 Improved recombinant human follicle-stimulating hormone

Publications (1)

Publication Number Publication Date
SMT201600219B true SMT201600219B (it) 2016-08-31

Family

ID=43242604

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600219T SMT201600219B (it) 2010-08-04 2016-07-06 Ormone follicolo-stimolante ricombinante umano migliorato

Country Status (27)

Country Link
US (1) US9527899B2 (it)
EP (2) EP2601210B1 (it)
JP (2) JP6001534B2 (it)
KR (1) KR20130136448A (it)
CN (2) CN103068839B (it)
AR (1) AR082852A1 (it)
AU (1) AU2011287525B2 (it)
BR (1) BR112013004051A2 (it)
CA (1) CA2805134C (it)
CU (1) CU24043B1 (it)
CY (1) CY1117778T1 (it)
DK (1) DK2601210T3 (it)
EA (1) EA029955B1 (it)
ES (2) ES2576868T3 (it)
HR (1) HRP20160671T1 (it)
HU (1) HUE028357T2 (it)
IL (1) IL223867B (it)
MX (1) MX336489B (it)
NZ (1) NZ604877A (it)
PL (1) PL2601210T3 (it)
PT (1) PT2601210T (it)
RS (1) RS54905B1 (it)
SG (1) SG186755A1 (it)
SI (1) SI2601210T1 (it)
SM (1) SMT201600219B (it)
WO (2) WO2012016576A1 (it)
ZA (1) ZA201209436B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) * 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
AR090095A1 (es) 2011-06-06 2014-10-22 Ferring Bv Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
EP3572515B1 (en) * 2012-07-30 2021-07-21 Trophogen Inc. Glycoprotein hormone long-acting superagonists
CN104543416B (zh) * 2013-10-09 2018-06-19 中国科学院大连化学物理研究所 一种调节雌性动物繁殖性能的功能性单糖饲料及其应用
CN103740754B (zh) * 2013-10-25 2015-06-24 中国食品药品检定研究院 含有鼠神经生长因子的表达载体及细胞
BR112016023668A2 (pt) * 2014-04-18 2017-10-17 Glycotope Gmbh hiperestimulação ovariana controlada com hormônio de estimulação de folículo humano recombinante aperfeiçoado
EP3091033A1 (en) * 2015-05-06 2016-11-09 Gamamabs Pharma Anti-human-her3 antibodies and uses thereof
WO2017025566A1 (en) * 2015-08-10 2017-02-16 Glycotope Gmbh Improved recombinant factor vii
EA201890163A1 (ru) * 2015-09-17 2018-10-31 Гликотоп Гмбх Композиция фолликулостимулирующего гормона млекопитающего с повышенной стабильностью
CN106053861A (zh) * 2016-07-28 2016-10-26 高常青 一种卵泡刺激素生物活性强度检测方法
CA3160345A1 (en) * 2019-11-06 2021-05-14 The Regents Of The University Of Colorado, A Body Corporate Modified follicle-stimulating hormone and methods of using the same
CN115160436A (zh) * 2021-09-07 2022-10-11 苏州晟济药业有限公司 高亲和力单域抗体或其抗原结合片段及其应用
EP4519296A1 (en) * 2022-05-06 2025-03-12 The Regents of the University of Colorado, a body corporate Modified follicle-stimulating hormone and methods of using the same
IT202200023037A1 (it) * 2022-11-08 2024-05-08 Oncogreen Therapeutics S A Composti per l’uso nella riprogrammazione dei macrofagi
IT202200023031A1 (it) * 2022-11-08 2024-05-08 Oncogreen Therapeutics S A Composto ad effetto anti-metastatico

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1176976B2 (en) 1999-05-07 2015-10-21 Laboratoires Serono SA Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women
UA87433C2 (ru) * 2001-10-22 2009-07-27 Еплайд Рісьорч Системз Ерс Холдінг Н.В. Гонадотропины для стимулирования фолликулогенеза
EP1725673A1 (en) * 2004-02-13 2006-11-29 Glycotope Gmbh Sialytated glycoproteins-process conditions and an efficient method for their production
PT2073842E (pt) * 2006-09-10 2015-04-07 Glycotope Gmbh Utilização de células humanas provenientes de uma leucemia mielóide para expressão de anticorpos
GB2459641B (en) * 2008-04-16 2012-06-27 Ubiquisys Ltd Basestation power control
TWI488640B (zh) * 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone

Also Published As

Publication number Publication date
AU2011287525B2 (en) 2014-09-25
AU2011287525A1 (en) 2013-01-17
JP6001534B2 (ja) 2016-10-05
IL223867B (en) 2018-04-30
EA201390194A1 (ru) 2013-06-28
HRP20160671T1 (hr) 2016-09-23
DK2601210T3 (en) 2016-07-04
JP2013535481A (ja) 2013-09-12
HUE028357T2 (en) 2016-12-28
EA029955B1 (ru) 2018-06-29
PL2601210T3 (pl) 2016-11-30
ES2576868T3 (es) 2016-07-11
BR112013004051A2 (pt) 2016-07-05
CU20130019A7 (es) 2013-05-31
CY1117778T1 (el) 2017-05-17
PT2601210T (pt) 2016-07-07
JP2016168055A (ja) 2016-09-23
EP2601210B1 (en) 2016-05-11
RS54905B1 (sr) 2016-10-31
CA2805134A1 (en) 2012-02-09
KR20130136448A (ko) 2013-12-12
SG186755A1 (en) 2013-02-28
SI2601210T1 (sl) 2016-09-30
MX336489B (es) 2016-01-21
WO2012017058A1 (en) 2012-02-09
US9527899B2 (en) 2016-12-27
WO2012017058A8 (en) 2016-04-07
CA2805134C (en) 2020-01-28
CN106146646A (zh) 2016-11-23
WO2012016576A1 (en) 2012-02-09
EP2601210A1 (en) 2013-06-12
CN103068839B (zh) 2016-06-22
MX2013000500A (es) 2013-02-21
NZ604877A (en) 2014-09-26
CN103068839A (zh) 2013-04-24
ES2764083T3 (es) 2020-06-02
CU24043B1 (es) 2014-11-27
EP3075744B1 (en) 2019-12-18
AR082852A1 (es) 2013-01-16
US20130137636A1 (en) 2013-05-30
EP3075744A1 (en) 2016-10-05
ZA201209436B (en) 2014-02-26

Similar Documents

Publication Publication Date Title
FR18C1043I2 (fr) Therapie antivirale
BR112013013311A2 (pt) agente terapêutico de indução de citotoxicidade
DK2538984T3 (da) Kompressionsforbinding
FI20105569L (fi) Kehonsisäinen hoitolaite
DK3162386T3 (da) Implanterbare medicinske indretninger
EP2542086A4 (en) COMPOUNDS AND ITS THERAPEUTIC USE
BR112012033478A2 (pt) dispositivo médico
EP2595532A4 (en) IMPLANTABLE DIELECTROMETER
DK2525798T3 (da) Anæstetisk formulering
ZA201209436B (en) Improved recombinant human follicle-stimulating hormone
DK2539015T3 (da) Nethindeprotese
EP2543405A4 (en) SYRINGE
DK2652652T3 (da) Medikmentadministration
EP2552212A4 (en) IMPROVED FORMULATION
DK2613888T3 (da) Doseringsanordning
EP2531023A4 (en) IMPROVED FORMULATION
HRP20160929T1 (hr) Terapijski režimi
EP2415408A4 (en) Treatment device
EP2557088A4 (en) PHYSIOLOGICALLY ACTIVE PEPTIDES
GB201011411D0 (en) Therapeutic compounds and their use
EP2614824A4 (en) THERAPEUTIC AGENT AGAINST PAIN
DK2420219T3 (da) Indgivelsesport
SI2536400T1 (sl) Zdravilo, ki vsebuje miramistin
LT2555790T (lt) ß2-MIKROGLOBULINO BALTYMO TERAPINIS PANAUDOJIMAS
IT1403367B1 (it) Dispositivo elettromedicale wireless